brain cancer

Massive cancer gene search finds potential new targets in brain ...

EurekAlert! - Cancer  Wed, 09/03/2008 - 23:00

(Dana-Farber Cancer Institute) An array of broken, missing and overactive genes have been identified in a genetic survey of glioblastoma, the most common and deadly form of adult brain cancer, report scientists from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard.

The large-scale combing of the brain cancer genome confirms the key roles of some previously known mutated genes and implicates a variety of other genetic changes that may be targets for future therapies.


 

Collaboration between researchers yields more comprehensive port...

EurekAlert! - Cancer  Wed, 09/03/2008 - 23:00

(HudsonAlpha Institute for Biotechnology) A team including researchers at the HudsonAlpha Institute and Stanford University, together with colleagues from a number of other organizations, today publishes a comprehensive analysis of genomic variation in the brain cancer glioblastoma.

These results are the first from the Cancer Genome Atlas research network, a collaborative effort funded by the National Cancer Institute and the National Human Genome Research Institute of the National Institutes of Health.


 

ASTRO honors Boston brain cancer survivor with Survivor Circle A...

EurekAlert! - Medicine and Health  Tue, 09/02/2008 - 23:00

(American Society for Therapeutic Radiology and Oncology) The American Society for Therapeutic Radiology and Oncology has selected Debra DeMella as the recipient of the 2008 Survivor Circle Award.

Ms. DeMella will receive her award and a $1,000 check to be given to the charity of her choice Monday, Sept. 22, 2008, at 1 p.m. during ASTRO's 50th Annual Meeting, which will take place Sept. 21-25, 2008, at the Boston Convention and Exhibition Center.


 

Brain cancer study: Magnitude of post-vaccine immune response li...

EurekAlert! - Cancer  Mon, 07/14/2008 - 23:00

(Cedars-Sinai Medical Center) Researchers conducting a clinical trial of a dendritic cell vaccine designed to fight malignant brain tumors called glioblastoma multiforme have found a correlation between the "intensity" of a patient's immune response and clinical outcome, according to an article in the July 15 issue of the journal Cancer Research.


 

Experts: Experimental meds an option for Kennedy

Headlines from the Associated Press  Mon, 06/09/2008 - 12:54

Sen. Edward M. Kennedy is back home from brain cancer surgery with something he didn't have before: lots of treatment options....


 

The fight of our lives

NYDailyNews.com - Health - NY Daily News  Mon, 06/09/2008 - 07:23

Like most people, I was stunned by the news Sen. Ted Kennedy had a seizure and was later diagnosed with advanced brain cancer.

I also thought about how having a seizure followed by a diagnosis of brain cancer was something we had in common.


 

Sen. Ted Kennedy to Get Brain Surgery

WebMD Health  Mon, 06/02/2008 - 00:00

Sen. Edward Kennedy, 76, will get brain surgery for his brain cancer at Duke University Medical Center.


 

Sen. Ted Kennedy Leaves Hospital

WebMD Health  Wed, 05/21/2008 - 00:00

Sen. Edward Kennedy, diagnosed with brain cancer, headed to his Cape Cod, Mass., home after being discharged from Massachusetts General Hospital.


 

Kennedy's Brain Cancer: How Bad?

TIME: Top Science and Health Stories  Tue, 05/20/2008 - 17:45

photoThe senator's seizure is diagnosed as a malignant tumor.

But his chances of survival depend on exactly what type it is



 

Measuring medicine: How new technologies could help doctors pred...

EurekAlert! - Cancer  Tue, 04/15/2008 - 23:00

As potential cancer therapies proliferate, researchers and clinicians are striving to measure their effectiveness and to more accurately predict which patients will receive the most benefit.

At the American Association for Cancer Research 2008 Annual Meeting, April 12-16, 2008, researchers present data on a new role for MRI in brain cancer, how doctors can more effectively measure response to commonly used cancer drugs, and a unique method for predicting the risk of breast cancer spread.